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Abstract
The viral transactivator of HTLV-I, Tax, has long been shown to target the earliest steps of
transcription by forming quaternary complexes with sequence specific transcription factors and
histone-modifying enzymes in the LTR of HTLV-I. However, a new study suggests that Tax
preferentially transactivates the 21-bp repeats through CREB1 and not other bZIP proteins. The
additional transactivation of Tax-responsive promoters subsequent to initiation is also presented.
This result highlights a potentially novel role of Tax following TBP recruitment (i.e. initiation) and
may expand the mechanism of Tax transactivation in promoter clearance and transcriptional
elongation.
Viruses have long been a source of key scientific discover-
ies. Historically, they have contributed to our knowledge
of transcription, cell cycle, and apoptosis. To date acti-
vated transcription in higher eukaryotic cells with or with-
out chromatin is a great area of active research and many
researchers use viral activators, including herpes virus
VP16, adenovirus E1A, HIV-1 Tat and HTLV-I Tax to not
only understand viral, but also basic mechanisms related
to host control of vital cellular machineries, including
transcription. Eukaryotic transcription has five distinct
phases, pre-initiation, initiation, promoter clearance,
elongation and termination, and is a tightly regulated and
coupled process [1]. Viral transactivators, such as Tax,
have long been shown to target the earliest steps of tran-
scription by forming quaternary complexes with sequence
specific transcription factors and histone-modifying
enzymes in the LTR of HTLV-I. These Tax-containing com-
plexes allow for increased recruitment of TBP (TFIID),
GTFs, and RNAP II within the core promoter region, lead-
ing to the synthesis of viral RNA. However, determination
of those cellular factors important for enhanced transcrip-
tional activity, as well as the full scope of Tax transactiva-
tion, is still not fully elucidated.
In the report by Ching et al. [2] the authors directly com-
pare which HTLV-I enhancer motif is preferred by Tax.
Each enhancer element (21-bp, CRE, AP1, SP1, κB, or
SRE) was placed in an identical TATAA-context to generate
a minimal HTLV-I promoter. Previous studies had utilized
various promoters (which contain additional DNA ele-
ments) to highlight a particular enhancer element neces-
sary for Tax transactivation. Thus, this is the first study to
directly compare these elements in an identical setting. In
the presence of Tax, the 21-bp repeat (also known as the
viral CRE elements or TxREs) was found to be most
responsive (70-fold above basal levels). The 21-bp repeat
was clearly preferred by Tax, since other enhancer ele-
ments were only stimulated 10-fold or less. Previously,
several studies suggested that Tax activation of the 21-bp
repeats may be mediated by ATF-4 [3-5]. It was shown
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that Tax was able to interact with ATF-4 bound to the 21-
bp repeats, enhance the binding of ATF-4 to the enhancer,
and recruit CREB binding protein (CBP) to the viral pro-
moter [5]. Recently, CREB1 and ATF-4, in addition to ATF-
1 and ATF-2, were found to be present in vivo on the 21-
bp repeats (viral CRE elements) in HTLV-I infected cells
through chromatin immunoprecipitation (ChIP) assays
[6]. By using dominant negative mutants of CREB1, ATF-
4 (CREB2/TAXREB67), Fos, and LZIP, Ching et al. demon-
strated that among the various bZIP proteins, CREB1 was
clearly favored for Tax transactivation of the 21-bp
repeats. Additionally, CREB1 has also been found to pri-
marily bind at the 5' LTR (rather than the 3' LTR) in vivo
within HTLV-I infected cells, lending support to the idea
that CREB1 is important for HTLV-I activated transcrip-
tion [7].
If CREB1 is the dominant bZIP protein that is needed for
Tax transactivation of the LTR, then what is the purpose of
the additional bZIP proteins? Besides contributing to Tax
transactivation, could these bZIP proteins help to exclude
negative regulators from the LTR? A report by Basbous et
al. [8] suggested that HBZ, which negatively down-regu-
lated transcription from the HTLV-I LTR, heterodimerized
with ATF-4 and subsequently this complex was no longer
able to bind to the 21-bp repeats. Only over-expression of
ATF-4 was found to reverse the negative effects of HBZ on
Tax activity. However, additional studies are still needed
to understand the respective contribution of CREB1 and
other bZIP proteins, such as ATF-4, to Tax transactivation
in the context of wildtype virus and stably integrated viral
promoters (i.e. correctly assembled chromatinized DNA
templates both in vitro and in vivo).
Lastly, Ching et al. presented the intriguing possibility of
Tax enhancing transcription following transcription initi-
ation. To determine whether Tax functioned solely to tar-
get TBP to the TATAA-element or if additional events
subsequent to TBP (TFIID) recruitment were promoted by
Tax, the authors constructed four independent reporters.
Each promoter contained the minimal TATAA-element
from HTLV-I, HIV-1, SV-40, or E1b promoters, two 21-bp
repeats, and five copies of the Gal4-binding site. TBP was
artificially targeted to the TATAA-element thru Gal4-TBP.
The authors reasoned that if Tax functioned strictly to
recruit TBP to the TATAA-element, then additional
enhancement of transcription would not be observed
when Tax and Gal4-TBP were present. Interestingly, only
the Tax-responsive promoters, i.e. HTLV-I and HIV-1, were
both synergistically stimulated by the addition of Tax and
Gal4-TBP. These results suggest that Tax may control
downstream transcription subsequent to the initiation
phase.
Other viral transactivators have been shown to have a role
at initiation and downstream events, such as elongation.
The most notable of these has been Tat, the viral transac-
tivator of HIV-1. Without cellular stimulation and Tat
expression, RNAP II transcriptional elongation was shown
to be inefficient, producing only short transcripts [9]. One
major contributing factor of Tat-dependent transactiva-
tion is the elongation factor, pTEFb. pTEFb, composed of
cyclin T1 and cdk9, associates with Tat leading to
increased phosphorylation at specific sites on the heptad
repeats of the CTD of RNAP II and promoting elongation.
Elongation is highly dependent on the status of RNAP II
CTD, since dissociation/association of factors have been
shown to be dependent on CTD serine 5/serine 2 phos-
phorylation [1,10]. Hyperphosphorylation of CTD at ser-
ine 5 is associated with promoter clearance/early
elongation, whereby initiation factors are released and the
5'capping machinery subsequently recruited. During
processive elongation, there is a switch in CTD phospho-
rylation to serine 2 phosphorylation resulting in the loss
of the capping machinery and the association of splicing,
elongation and chromatin remodeling factors. In the case
of HTLV-I, Tax has been shown not to associate with a
CTD kinase [11] and a dominant negative mutant of cdk9
(the catalytic subunit of pTEFb) was found to increase Tax
transactivation of the HTLV-I promoter [12]. Therefore,
there is the possibility that other kinase complexes (small
vs. large pTEFb complex or other cdk kinases) may aid in
increased Tax transactivation. In this context, HTLV-I
infected cells contain increased levels of cyclin E/cdk2
kinase activity, through sequestration of cdk inhibitor,
p21/waf1, by cyclin D2/cdk4 complexes [13,14]. This
kinase complex was able to phosphorylate RNAP II CTD
and antibodies against cyclin E co-immunoprecipitated
only the phosphorylated form of RNAP II from HTLV-I
infected cells. Thus, if only indirectly, Tax may increase
kinase activity resulting in enhanced CTD phosphoryla-
tion for steps following initiation, such as promoter clear-
ance and/or elongation.
Processive elongation is highly dependent on remodeling
of chromatin structure [1,10]. A study by Corey et al. [15]
demonstrated that disruption of SWI/SNF recruitment by
an activator resulted in lack of chromatin remodeling,
transcription elongation, and production of full-length
hsp70 mRNA. Tax has been shown to associate with BRG1
components of the ATP-dependent chromatin remode-
ling complex, SWI/SNF, and increase Tax transactivation
[16]. Disruption of BRG1 by siRNA led to a decrease in
Tax transactivation. Therefore, Tax may target SWI/SNF
complexes downstream of RNAP II in order to prevent
stalling of RNAP II. This raises a number of questions such
as does Tax bind to an elongating RNAP II complex? Does
Tax help to recruit elongation factors, such as TFIIS or
TFIIF? Finally, it should be emphasized that each stage ofRetrovirology 2004, 1:19 http://www.retrovirology.com/content/1/1/19
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transcription is not an independent process; coupling of
the transcriptional and RNA processing machinery is
thought to increase the rate and specificity of these enzy-
matic reactions [1]. As shown in Figure 1A, acetylation of
nucleosomes and other transcription factors/coactivators
promote an open complex structure and RNAP II holoen-
zyme assembly. Initiation by Tax is dependent on the
recruitment of CBP/p300 and p/CAF by transcription fac-
tor/Tax complex at the 21-bp repeats (viral CRE ele-
ments). Phosphorylation of RNAP II CTD is important for
loading of the 5' capping machinery to allow for rapid
capping of nascent pre-mRNA, ensuring protection for the
transcript from degradation. During promoter clearance
(early elongation), site specific phosphorylation of the
CTD is modified to allow for sequestration of splicing
machinery and elongation factors, and release of the cap-
ping machinery. Assembly of SWI/SNF factors with Tax
downstream of the elongation phase RNAP II complex
remodels chromatin structure, promoting RNAP II proces-
sivity. Thus, the presence of Tax for initiation and possibly
promoter clearance and/or elongation will help to
increase viral transcription and mRNA processing overall
Effect of Tax on transcription Figure 1
Effect of Tax on transcription. A) Schematic representation of proximal promoter of HTLV-I. Tax binding to CBP/p300 
with either p/CAF or bZIP transcription factors (e.g. CREB1) leads to increased acetylation and interaction with the basal tran-
scription machinery. Tax binding to SWI/SNF downstream of start site may help to remodel restrictive chromatin structure 
and aid in promoter clearance and elongation. B) The possible effect of Tax on gene expression network. The sequential steps 
of transcription (initiation, elongation, and termination) are intricately linked together and to mRNA processing and export 
(adapted from ref. 1). Thus, the effect of Tax on initiation and possibly elongation (both early promoter clearance and proces-
sive elongation events) would contribute, albeit indirectly, to RNA processing and export.
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(Figure 1B). While the results by Ching et al. are prelimi-
nary at this time, Tax transactivation post-initiation is
indeed a novel concept. Further detailed analysis of Tax at
both the LTR of HTLV-I and downstream of this region
will help to resolve many of these questions and provide
important insight into the transcription field.
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